Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

The Stratus COVID-19 variant, which includes the XFG and XFG.3 strains, currently accounts for around 30 per cent of COVID-19 ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Medical associations representing hundreds of thousands of doctors, medical professionals and scientists in the United States ...

South Africa’s health ministry has expressed concern about a persistent campaign of Covid-19 vaccine disinformation ...

A conservative podcast group organized an event in support of Dr. Kirk Moore, accused in federal court of discarding COVID-19 ...

Xu Zewei is charged in a nine-count indictment in the Southern District of Texas for his alleged involvement in computer ...

Public hearings for the second phase of the Royal Commission of Inquiry into Covid-19 Lessons Learned began in Auckland this ...

New research reveals that virtual maternity care during the COVID-19 pandemic may have driven increased use of subsequent ...

A Ponte Vedra Beach man pleaded guilty to several charges in connection with a fraud scheme involving COVID-19 personal ...